ImmunityBio
IBRX
#2057
Rank
NZ$17.30 B
Marketcap
NZ$16.53
Share price
2.61%
Change (1 day)
268.53%
Change (1 year)

Market capitalization of ImmunityBio (IBRX)

Market cap: NZ$17.30 Billion

As of July 2026 ImmunityBio has a market cap of NZ$17.30 Billion. This makes ImmunityBio the world's 2057th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ImmunityBio from 2021 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$17.30 B375.59%
2025NZ$3.63 B1.12%
2024NZ$3.59 B-32.09%
2023NZ$5.30 B65.81%
2022NZ$3.19 B-9.72%
2021NZ$3.54 B

End of Day market cap according to different sources

On Jul 4th, 2026 the market cap of ImmunityBio was reported to be:

NZ$17.30 Billion
by Nasdaq info icon info icon
NZ$17.30 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ORIC Pharmaceuticals
ORIC
NZ$2.10 B-87.81%๐Ÿ‡บ๐Ÿ‡ธ USA